表 5.

EORA合并CVD危险因素

Risk factors of CVD in patients with EORA

Risk factors	OR (95%CI)	P value
Abbreviations as in Table 1 and Table 2.
Male	0.73 (0.27, 1.97)	0.536
Age	1.10 (1.00, 1.20)	0.040
Disease duration	0.99 (0.87, 1.12)	0.819
SJCs	0.91 (0.24, 3.53)	0.894
TJCs	0.90 (0.20, 3.99)	0.889
DJCs	3.17 (1.04, 9.68)	0.043
ESR	1.92 (0.50, 7.39)	0.344
CRP	0.62 (0.21, 1.84)	0.386
Anti-CCP antibody	0.48 (0.14, 1.65)	0.243
DAS28-ESR
>2.6, ≤3.2	0.11 (0.01, 1.50)	0.098
>3.2, ≤5.1	0.59 (0.07, 4.92)	0.629
>5.1	0.67 (0.23, 1.98)	0.473
ILD	0.77 (0.38, 1.57)	0.464
Anemia	1.19 (0.48, 2.93)	0.712
Rheumatoid nodules	3.56 (1.03, 12.23)	0.044
Hydroxychloroquine	0.22 (0.07, 0.70)	0.011
Methotrexate	0.32 (0.14, 0.73)	0.007
Sulfasalazine	0.69 (0.28, 1.75)	0.440
Leflunomide	1.03 (0.46, 2.31)	0.949
Corticosteroid	1.09 (0.46, 2.59)	0.854
Celecoxib	0.66 (0.12, 3.55)	0.628
Biological	0.39 (0.10, 1.58)	0.188
24≤BMI < 28	3.41 (0.27, 42.55)	0.341
BMI≥28	3.42 (0.26, 44.26)	0.347
Smoking	1.66 (0.58, 4.80)	0.347
Hypertension	2.37 (1.09, 5.13)	0.029
Diabetes	0.94 (0.37, 2.40)	0.900
Hyperlipemia	8.85 (2.50, 31.27)	0.001